for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Business

Cost cutting boosts Merck's profit

Posted

April 29 - Merck offset patent expirations on drugs by drastically slashing R&D costs. It's in talks to sell its consumer unit to Reckitt Benckiser. Fred Katayama reports.

Business

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up